Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic

Study Procedures:

On admission or during the outpatient visit:

• Obtaining an informed consent .
• Full medical history, concurrent medications, demographic data and epidemiological data (history of contact to a COVID-19 case, history of travel), will be obtained.
• A thorough physical examination will be performed.
• Body weight, height, BMI, vital signs (blood pressure, heart rate and temperature) and blood oxygen saturation) will be recorded.
• Laboratory to perform the following tests:

Complete blood count with differential counts, COVID -19 reverse Transcription Polymerase Chain Reaction (RT-PCR) test by nasopharyngeal swab.

During admission:

Whenever unexplained fever and or respiratory symptoms developed or whenever COVID19 suspected to have the following to be performed:

• Symptom developed that necessitates to repeat oropharyngeal and nasopharyngeal swab if indicated will be collected
• Chest X-ray or CT chest will be recorded.
• Laboratory to perform the following tests:

Complete blood count with differential counts,

COVID-19 RT-PCR test by oropharyngeal and nasopharyngeal swab:

C-reactive protein and serum ferritin level. Coagulation test; D. dimer, prothrombin time and INR. Routine bacteriological study, blood culture and other symptoms/signs based cultures will be recorded

On discharge:

• Date of discharge
• Period of admission
• Period of fever
• A thorough physical examination will be performed
• Record the outcome

Inclusion criteria

• Children below 18 years with malignancy either hematological or solid tumors or
• Children below 18 years with hematological condition

Exclusion criteria

• Patients or care-givers refusal to be enrolled in the study